Comparative National Prescriptive and Dosimetric Characteristics of Beta-Blocker Therapy in Asian Heart Failure Patients
Jonathan Kenigson · Cardiology and Angiology: An International Journal · 2025
Beta-blocker therapy remains a cornerstone of heart failure (HF) management, but its role in Asian populations is shaped by unique pharmacogenomic and economic factors. Registry data show prescription rates ranging from 61% in Indonesia to 91% in Japan, with consistently favorabl...
Open access
Research Article
10.9734/ca/2025/v14i4505